Torii Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Torii Pharmaceutical Stock Forecast and Price Target
The average target price for Torii Pharmaceutical's stock set by renowned analysts in recent months is ¥4350.00, representing a potential upside of approximately 12.84% from its last closing price if met by 2025. This estimation is based on a high estimate of ¥4700.00 and a low estimate of ¥4000.00. Even if you are not interested in 4551 stock, you should be aware of its competitors and their current standings.
12.84% Upside
Torii Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Torii Pharmaceutical's Revenue has grown by 31.03%, rising from ¥41.70B to ¥54.64B. For the following year, the 0 analysts predict that Torii Pharmaceutical's Revenue will drop by 8.55%, reaching ¥49.96B. In 2030, the professionals' prediction is that 4551's Revenue will decrease by 8.77%, reaching ¥49.85B.
.jpg)
Torii Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
Torii Pharmaceutical's EBITDA has seen impressive growth In the last three years, rising from ¥5.32B to ¥5.50B – a growth of 3.27%. According to the 0 analysts polled, in the next year, Torii Pharmaceutical's EBITDA will fall by 0.46%, reaching ¥5.47B. For the next seven years, the forecast is for EBITDA to grow by 0.13%.
Torii Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Torii Pharmaceutical's EBIT has grown by 6.27%, rising from ¥4.74B to ¥5.04B. For the next year, 0 analysts project Torii Pharmaceutical's EBIT to drop by 1.39%, reaching ¥4.97B. By 2030, professionals believe that Torii Pharmaceutical's EBIT will decrease by 0.12%, reaching ¥5.03B – a concerning trend for the company.
.jpg)